Background Although patients with cardiovascular disease face excess risks of severe
illness with coronavirus disease-2019 (COVID-19), there may be indirect consequences of …

Objectives. To determine the magnitude of increases in monthly drug-related overdose
mortality during the COVID-19 pandemic in the United States. Methods. We leveraged …

The evolving nature of the opioid epidemic and continued increases in overdose deaths
highlight a need for fundamental change in the collection and use of surveillance data to link …

Background: Fentanyl-related deaths continue to increase in the United States; however,
most national studies focus on fatal overdose. More research, including data on nonfatal …

The COVID-19 pandemic in the US has been largely monitored using death certificates
containing reference to COVID-19. However, prior analyses reveal that a significant …

Background Reports analyzing drug overdose (OD) mortality data during the COVID-19
pandemic are limited. Outcomes across states are heterogenous, necessitating …

In the United States, estimates of excess deaths attributable to the COVID-19 pandemic
have consistently surpassed reported COVID-19 death counts. Excess deaths reported to …

Objective: This study examined cumulative excess mortality in European countries in the
year of the Covid-19 pandemic and characterized the dynamics of the pandemic in different …

As overdose mortality is spiking during the COVID-19 pandemic, few race/ethnicity-stratified
trends are available. This is of particular concern as overdose mortality was increasing most …

Background Timely data is key to effective public health responses to epidemics. Drug
overdose deaths are identified in surveillance systems through ICD-10 codes present on …